BiotechTube
Home/BioMimetix JV/Shayne Gad, PhD
SG

Shayne Gad, PhD

VP of Drug Safety, Regulatory Affairs

BioMimetix JV

Therapeutic Areas

OncologyInflammatory Diseases

BioMimetix JV Pipeline

DrugIndicationPhase
BMX-001High-Grade GliomaPhase 3 (preparing)

Leadership Team at BioMimetix JV

JC
James Crapo, MD
CEO
RH
Rob Hellewell
President & Chief Business Officer
DS
David S Silberstein, PhD
VP of R&D
RO
Robert Ogden, CPA
CFO
SP
Sara Penchev
Director of Clinical Operations
JW
John Wetzel, PhD
Director, Chemistry, Manufacturing and Controls
View full BioMimetix JV profile